Specimen Validity Testing Market Size

Specimen Validity Testing Market Size

Specimen Validity Testing Market size was valued at around USD 2.4 billion in 2022 and is projected to reach over USD 4.7 billion by the end of 2032. This incremental growth rate is owing to increasing incidence of illicit drug abuse coupled with rising awareness regarding specimen validity testing and surging demand for rapid and point of care testing.

To get key market trends

  Download Free Sample

Technological advancements pertaining to specimen validity testing in urine test to analyze adulterants, substitution and dilution is expected to augment the market growth in the forecasted timeframe. Rising healthcare spending for providing better healthcare infrastructure and increasing disposable income are some of the major factors responsible for increased adoption of specimen validity testing devices and services across the world.

Specimen validity testing (SVT) is a process used to assess the integrity and authenticity of biological samples, typically urine, in various testing scenarios, such as drug testing. This testing is intended to verify that the submitted sample has not been adulterated, substituted, diluted, or tampered with in any way that could potentially alter the test results.

However, high cost of specimen validity testing can be a significant barriers and impede the market growth in the coming years. Specimen validity testing (SVT) can involve additional costs beyond the standard drug testing procedures. These test often requires specialized equipment and reagents to assess the integrity of samples accurately. These may include instruments for measuring temperature, pH, specific gravity, and specific chemical reagents for detecting adulterants or masking agents. The procurement, maintenance, and calibration of such equipment, as well as the purchase of specific reagents, can add to the overall cost of SVT. For instance, the cost of creatinine specimen validity test calibrators can range between USD 800 to USD 2,000 and may vary according to the test type. Thus, high end pricing of equipment and services can restrict their use in developing economies, thereby limiting their use up to certain extent. Hence, the aforementioned factors are expected to restrict the market growth.